Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
28 Sep 2014 ESMO 2014 Press Release: Treatments for Advanced Cancer Less Available in Eastern Europe, Reveals ESMO Survey Bioethics, legal and economic issues
28 Sep 2014 ESMO 2014 Press Commentary: CLEOPATRA Trial Changes Standard Therapy for Metastatic HER2 Positive Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: MAGRIT Phase III Trial Results Raise Questions About the Future of Lung Cancer Vaccination Lung and other thoracic tumours - Immuno-oncology
28 Sep 2014 ESMO 2014: Bevacizumab Maintenance in HER2-Negative Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
28 Sep 2014 The Promise of Tumour-Infiltrating Lymphocytes for Cancer Treatment and as Prognostic/Predictive Indicators Breast cancer - Immuno-oncology
28 Sep 2014 How an Understanding of Melanoma Development is Changing the Clinical Landscape of its Treatment Melanoma
28 Sep 2014 ESMO 2014 Press Release: Many Patients Lack Information About the Use of Targeted Therapies, Oncologists Say Bioethics, legal and economic issues
28 Sep 2014 ESMO 2014 Press Release: Significant Presence of Women in Oncology, but Still Under-Representation in Leadership Positions, Greek Survey Shows Bioethics, legal and economic issues
28 Sep 2014 Metastatic NSCLC: New Findings, New Avenues to Explore Lung and other thoracic tumours
28 Sep 2014 Pathway of the Day: Hedgehog Pathology/Molecular biology
28 Sep 2014 ESMO 2014: Second-Line Targeted Treatments in Patients with Advanced Hepatocellular Carcinoma Gastrointestinal cancers - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: Adding Cediranib to Chemotherapy Improves Progression-Free Survival for Metastatic or Recurrent Cervical Cancer, Phase II Trial Shows Gynaecologic malignancies - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: Pertuzumab Adds 16 Months Survival Benefit to Trastuzumab and Chemotherapy Treatment for HER2-Positive Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: IMPRESS Trial Data on Continuing Tyrosine Kinase Inhibitor Therapy After Resistance Development in Lung Cancer Reported Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014 Press Commentary: Phase III Trials Presented at ESMO 2014 Report Major Advances in Supportive Care for Cancer Patients Palliative and supportive care